Arthur M. Cohen & Associates LLC Has $4.76 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Arthur M. Cohen & Associates LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,818 shares of the medical equipment provider’s stock after purchasing an additional 446 shares during the period. Intuitive Surgical makes up 0.9% of Arthur M. Cohen & Associates LLC’s holdings, making the stock its 22nd largest position. Arthur M. Cohen & Associates LLC’s holdings in Intuitive Surgical were worth $4,759,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth about $26,000. Godsey & Gibb Inc. boosted its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. Creekmur Asset Management LLC boosted its stake in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the last quarter. LGT Financial Advisors LLC boosted its stake in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the last quarter. Finally, Delos Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 240 shares of the stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,558,968.56. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, EVP Robert Desantis sold 240 shares of the stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,558,968.56. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Mark Brosius sold 2,115 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the sale, the insider now owns 295 shares in the company, valued at $145,113.45. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock worth $33,839,308 in the last quarter. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 0.3 %

Shares of NASDAQ:ISRG opened at $508.91 on Tuesday. The company’s 50 day moving average price is $490.97 and its two-hundred day moving average price is $448.54. Intuitive Surgical, Inc. has a 12-month low of $269.49 and a 12-month high of $523.34. The firm has a market cap of $181.26 billion, a PE ratio of 81.58, a PEG ratio of 4.98 and a beta of 1.39.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Mizuho upped their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.